Developer docs
API playgroundTry for free, no card

Search company profiles

MAOLAC

Full company profile

uuid0005te3

Namestring
MAOLAC
Legal namestring
Maolac Ltd.
Websiteurl
maolac.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

MAOLAC is a privately held Israeli foodtech and biotechnology company headquartered in Tirat HaCarmel, Israel, founded in 2020/2021 by Maya Ashkenazi Otmazgin. The company develops and sells colostrum-based bioactive protein ingredients to B2B customers — primarily vitamin and supplement brands (e.g., Lemme), functional food and beverage formulators, and medical nutrition companies — rather than finished consumer products. It operates with a team of 11-50 employees and has raised approximately $5.6M in disclosed funding across seed and follow-on rounds led by OurCrowd and Mylkcubator. The company is certified to ISO 9001, halal, and kosher standards for its production facilities.

The company's core technology is the Maoreka™ AI-driven discovery platform, which uses computational biology, proteomics, and natural language processing to identify and extract functional proteins from bovine colostrum with high structural and functional similarity to human breast milk proteins. Its proprietary IgHM™ (human-compatible immune modulators) trademarked architecture replaces bovine IgG with protein domains that mirror human immune modulators, enabling claimed efficacy at 140-620 mg/day versus the 2-60 g/day typically required of standard colostrum. MAOLAC's branded product portfolio comprises four core ingredients: SuperColostrum™ (general wellness, 140 mg/day), MaolactinGI™ (gut health, 330-620 mg/day), MaolactinFMR™ (muscle recovery/mobility, 360 mg/day), and SuperColoSKN™ (skin health, launched 2026). COLOSTRUM 2.0 was launched in March 2026 for the clinical, practitioner, and premium formulation channel. Efficacy has been validated in randomized, double-blind, placebo-controlled human trials in Australia and Israel, with quantified outcomes including 35% reduction in GI symptom severity (GSRS, n=90), 38% reduction in indigestion, 52% reduction in bloating, 47% improvement in digestive quality of life, and a 900 U·h/L reduction in muscle damage markers in an 8-week trial (n=33).

MAOLAC operates a B2B ingredient sales model, generating revenue through ingredient supply agreements with brand and formulator customers. Distribution is handled through direct enterprise sales globally, supplemented by an exclusive North American distribution partnership with Caldic (announced February 2026, with commercial rollout planned for 2026). The company targets horizontal customer segments across gut health, muscle recovery, immunity, longevity, and skin health use cases. Its first flagship commercial brand partnership was with Lemme (Kourtney Kardashian Barker) in November 2025. The Scientific Advisory Board includes credentialed figures such as Dr. Michael Murray, Dr. Jacqueline Jacques, Dr. Sandra Einerhand, Prof. David C. Nieman, and Prof. Ilan Youngster.

Short descriptiontext

MAOLAC is an Israeli foodtech and biotechnology company that develops and sells clinically validated, AI-discovered colostrum-based bioactive protein ingredients to supplement brands, functional food formulators, and medical nutrition companies for gut, muscle, immune, and skin health applications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTirat Hakarmel, Israel
HQ citystring
Tirat Hakarmel
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
colostrum-based ingredients, bioactive protein ingredients, nutraceutical ingredients, functional food ingredients, dietary supplement ingredients
Industry3 codes
PRIMARYCRADAOAJ
Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids)
SECONDARYAFAJAHAB
Animal-Derived Protein Ingredients (Egg, Collagen/Gelatin, Blood/Plasma Proteins)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYAFAJAKAG
Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
NAICS code1 code
  • Dairy Product Manufacturing3115
SIC code1 code
  • Dairy Products2020
Product category
Nutraceutical Ingredients
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1B2B Ingredient Sales
TypeOne Time License
Description

Maolac develops and sells colostrum-based bioactive protein ingredients (SuperColostrum™, MaolactinGI™, MaolactinFMR™, SuperColoSKN™) to brands and formulators in the dietary supplement, functional food, beverage, and medical nutrition markets. Revenue is generated through ingredient supply agreements with brand partners.

maolac.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1SuperColostrum™
Description

The first colostrum optimized for human biology, delivering a wide range of demonstrated health benefits in just 140mg per day.

maolac.com
+5 more records
Core offering1 text field

MAOLAC develops and sells colostrum-based bioactive protein ingredients (SuperColostrum™, MaolactinGI™, MaolactinFMR™, SuperColoSKN™) to supplement brands, functional food formulators, and medical nutrition companies. The company uses its proprietary Maoreka™ AI-driven proteomics platform to identify and extract proteins from bovine colostrum with high biosimilarity to human breast milk proteins, delivering clinically validated ingredients effective at 140-620 mg/day.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 12 values shown
  • 35% reduction in overall gastrointestinal symptom severity (GSRS) in double-blind clinical trial (n=90)
+11 more records
Product overview1 text field

MAOLAC is a deep tech biotechnology company that has developed a portfolio of colostrum-based biofunctional proteins inspired by human breast milk. The product portfolio consists of four main branded ingredients: SuperColostrum™ (general wellness, 140mg/day), MaolactinGI™ (gut health/microbiome, 330-620mg/day), MaolactinFMR™ (muscle recovery/mobility, 360mg/day), and SuperColoSKN™ (skin health, 2026 launch). All products are developed using the proprietary Maoreka™ AI-driven discovery platform that identifies and extracts functional proteins from bovine colostrum with high biosimilarity to human breast milk proteins. The company positions these as precision nutrition ingredients suitable for dietary supplements, functional foods, beverages, and medical nutrition applications.

Product and service5 records
1SuperColostrum™
CategoryBioactive Protein Ingredient
Description

The first colostrum optimized for human biology, delivering demonstrated health benefits in gut health, vitality, fitness, beauty, and digestion at just 140mg per day. Features over 20% IgHM™ bioactive content, 7x more effective than standard bovine colostrum, and contains no residual veterinary drugs, hormones, or antibiotics. For B2B ingredient customers developing dietary supplement and functional nutrition products.

2MaolactinGI™
CategoryBioactive Protein Ingredient - Gut Health
Description

A clinically proven colostrum-based bioactive protein ingredient that supports gut health, promotes balanced microbiome, and helps reduce bloating, constipation, and abdominal discomfort. Works at the biological root to support healthier gut environment with proven symptom alleviation at 330-620 mg/day. The first bio-biotic protein system that goes beyond prebiotics, probiotics, and postbiotics. For B2B supplement and functional food brand customers.

3MaolactinFMR™
CategoryBioactive Protein Ingredient - Muscle Recovery
Description

A clinically validated colostrum-based ingredient for recovery, mobility, and healthy aging. Targets muscle damage and chronic low-grade inflammation (inflammaging) to support faster recovery, reduced soreness, and long-term mobility at just 360 mg/day. Backed by randomized double-blind, placebo-controlled clinical trial with 33 healthy active adults. For B2B sports nutrition, active nutrition, and healthy aging brand customers.

4SuperColoSKN™
CategoryBioactive Protein Ingredient - Skin Health
Description

Advanced colostrum designed specifically for human skin, delivering biofunctional proteins that support microbiome balance, inflammation control, and barrier function. Features 95%+ structural and functional similarity to human breast milk, 7x greater efficacy than generic colostrum, and 75%+ protein content. Targets anti-inflammatory action and skin resilience. For B2B skincare, beauty-from-within, and nutricosmetics brand customers.

5COLOSTRUM 2.0
CategoryBioactive Protein Ingredient - Clinical/Premium Grade
Description

AI-driven bovine colostrum ingredient that uses a proprietary 3D discovery platform to concentrate approximately 400 bioactive proteins with about 95% similarity to human biology. Designed for predictable microbiome modulation and clinically demonstrated digestive benefits at low daily doses. Targets clinical, practitioner, and premium formulation markets positioning for pharmaceutical-grade credibility.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-02-19
Description

Caldic, a global solutions provider for food and nutrition markets, partnered with Maolac to market and distribute Maolac's portfolio of colostrum-based ingredients across the North American nutrition sector. Products covered include Maolactin-GI, Maolactin-FMR, and Super Colostrum. Commercial rollout is planned for 2026. This is a key distribution partnership enabling Maolac to scale in the North American market.

Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2025-11-04
Description

Lemme, a vitamin and supplement brand founded by Kourtney Kardashian Barker, launched new gut health products (Lemme Colostrum Gummies and Lemme Colostrum Liposomal Liquid) formulated with Maolac's scientifically-supported colostrum ingredient. The product launch received strong consumer response and was featured in leading business publications.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Glanbia Nutritionals supplies whey proteins, milk proteins, and functional ingredient blends to supplement, performance, and food brands globally. It is a broad incumbent competing with Maolac in the dairy/functional-protein ingredient space with significantly greater scale and a wider customer base.

TypeBroad incumbent
Description

Arla Foods Ingredients is a global dairy ingredient supplier (whey proteins, milk fractions, lactose) serving nutrition, health, and performance-food customers worldwide. It is a broad incumbent that competes with Maolac on the dairy-protein ingredients shelf and benefits from much deeper distribution and customer penetration.

TypeBroad incumbent
Description

Kerry Group is a global taste and nutrition ingredients platform serving food, beverage, and supplement customers. It competes with Maolac in bioactive and functional ingredient categories through its nutrition portfolio and has the scale and customer breadth to bundle Maolac-style innovations into larger accounts.

TypeBroad incumbent
Description

ADM's Nutrition segment is a global supplier of plant- and animal-protein ingredients, flavors, and health-and-wellness solutions for CPG and supplement brands. It is a broad incumbent that addresses the same brand customers as Maolac through protein-ingredient offerings.

5Hilmar Ingredients
TypeBroad incumbent
Description

Hilmar Ingredients is a US-based manufacturer of whey protein and dairy ingredient solutions for nutrition and food brands. As an established dairy-protein ingredient incumbent with strong US manufacturing capacity, it overlaps with Maolac's positioning on functional protein ingredients for nutrition customers.

TypeDirect peer
Description

PanTheryx is a US-based bovine colostrum ingredient supplier offering branded colostrum powders and formulations for immune and GI health to dietary-supplement and nutrition-brand customers. It is the closest direct competitor to Maolac in colostrum-based B2B ingredients targeting the same supplement and functional-food brand channels.

TypeEmerging player
Description

SternVitamin is a premix and functional-ingredient supplier serving the European dietary-supplement and fortified-food industries. It is a smaller, ingredient-blending specialist whose customer base (vitamin and supplement brands) overlaps with Maolac's targeted B2B segments in functional nutrition formulations.

8APS Biogroup
TypeDirect peer
Description

APS Biogroup is a Switzerland-based manufacturer of hyperimmune bovine colostrum ingredients (including travelan/Colact/IMMUSE) for gut and immune health, sold primarily to dietary-supplement and functional-food brands. It directly competes with Maolac on colostrum-derived bioactive ingredients and pursues a similar B2B ingredient model.

TypeBroad incumbent
Description

Cargill supplies a broad portfolio of food and nutrition ingredients, including proteins and bioactives, to CPG and supplement manufacturers globally. It competes with Maolac in the functional-ingredient shelf and has the distribution network to reach every customer Maolac targets through Caldic and direct sales.

TypeBroad incumbent
Description

IFF's Health & Biosciences division produces probiotics, enzymes, and bioactive ingredients for nutrition and dietary-supplement brands. It is a broad incumbent with a microbial-protein discovery infrastructure that is adjacent and partially competitive with Maolac's AI-driven bioactive ingredient work.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MAOLAC

Nutraceutical Ingredientsmaolac.com

MAOLAC is an Israeli foodtech and biotechnology company that develops and sells clinically validated, AI-discovered colostrum-based bioactive protein ingredients to supplement brands, functional food formulators, and medical nutrition companies for gut, muscle, immune, and skin health applications.

What MAOLAC does

MAOLAC is a privately held Israeli foodtech and biotechnology company headquartered in Tirat HaCarmel, Israel, founded in 2020/2021 by Maya Ashkenazi Otmazgin. The company develops and sells colostrum-based bioactive protein ingredients to B2B customers — primarily vitamin and supplement brands (e.g., Lemme), functional food and beverage formulators, and medical nutrition companies — rather than finished consumer products. It operates with a team of 11-50 employees and has raised approximately $5.6M in disclosed funding across seed and follow-on rounds led by OurCrowd and Mylkcubator. The company is certified to ISO 9001, halal, and kosher standards for its production facilities.

The company's core technology is the Maoreka™ AI-driven discovery platform, which uses computational biology, proteomics, and natural language processing to identify and extract functional proteins from bovine colostrum with high structural and functional similarity to human breast milk proteins. Its proprietary IgHM™ (human-compatible immune modulators) trademarked architecture replaces bovine IgG with protein domains that mirror human immune modulators, enabling claimed efficacy at 140-620 mg/day versus the 2-60 g/day typically required of standard colostrum. MAOLAC's branded product portfolio comprises four core ingredients: SuperColostrum™ (general wellness, 140 mg/day), MaolactinGI™ (gut health, 330-620 mg/day), MaolactinFMR™ (muscle recovery/mobility, 360 mg/day), and SuperColoSKN™ (skin health, launched 2026). COLOSTRUM 2.0 was launched in March 2026 for the clinical, practitioner, and premium formulation channel. Efficacy has been validated in randomized, double-blind, placebo-controlled human trials in Australia and Israel, with quantified outcomes including 35% reduction in GI symptom severity (GSRS, n=90), 38% reduction in indigestion, 52% reduction in bloating, 47% improvement in digestive quality of life, and a 900 U·h/L reduction in muscle damage markers in an 8-week trial (n=33).

MAOLAC operates a B2B ingredient sales model, generating revenue through ingredient supply agreements with brand and formulator customers. Distribution is handled through direct enterprise sales globally, supplemented by an exclusive North American distribution partnership with Caldic (announced February 2026, with commercial rollout planned for 2026). The company targets horizontal customer segments across gut health, muscle recovery, immunity, longevity, and skin health use cases. Its first flagship commercial brand partnership was with Lemme (Kourtney Kardashian Barker) in November 2025. The Scientific Advisory Board includes credentialed figures such as Dr. Michael Murray, Dr. Jacqueline Jacques, Dr. Sandra Einerhand, Prof. David C. Nieman, and Prof. Ilan Youngster.

MAOLAC firmographics

Firmographics
Name
MAOLAC
Legal name
Maolac Ltd.
Website
https://maolac.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
MAOLAC is an Israeli foodtech and biotechnology company that develops and sells clinically validated, AI-discovered colostrum-based bioactive protein ingredients to supplement brands, functional food formulators, and medical nutrition companies for gut, muscle, immune, and skin health applications.
Ownership category
akta.pro rank

MAOLAC industry classification

Industry
Product category
Nutraceutical Ingredients
NAICS
Dairy Product Manufacturing (3115)
SIC
Dairy Products (2020)
akta.pro industry
PRIMARYCRADAOAJ
Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids)
SECONDARYAFAJAHAB
Animal-Derived Protein Ingredients (Egg, Collagen/Gelatin, Blood/Plasma Proteins)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYAFAJAKAG
Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)

Keywords

  • Colostrum-based ingredients
  • Bioactive protein ingredients
  • Nutraceutical ingredients
  • Functional food ingredients
  • Dietary supplement ingredients

Where MAOLAC is headquartered

Location

Headquarters

HQ city
Tirat Hakarmel
HQ country
Israel
HQ region
Middle East

Offices1 record

Markets served

MAOLAC business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. B2B Ingredient Sales: Maolac develops and sells colostrum-based bioactive protein ingredients (SuperColostrum™, MaolactinGI™, MaolactinFMR™, SuperColoSKN™) to brands and formulators in the dietary supplement, functional food, beverage, and medical nutrition markets. Revenue is generated through ingredient supply agreements with brand partners.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels7 records

MAOLAC product offering

Product offering

Core offering

MAOLAC develops and sells colostrum-based bioactive protein ingredients (SuperColostrum™, MaolactinGI™, MaolactinFMR™, SuperColoSKN™) to supplement brands, functional food formulators, and medical nutrition companies. The company uses its proprietary Maoreka™ AI-driven proteomics platform to identify and extract proteins from bovine colostrum with high biosimilarity to human breast milk proteins, delivering clinically validated ingredients effective at 140-620 mg/day.

Product overview

MAOLAC is a deep tech biotechnology company that has developed a portfolio of colostrum-based biofunctional proteins inspired by human breast milk. The product portfolio consists of four main branded ingredients: SuperColostrum™ (general wellness, 140mg/day), MaolactinGI™ (gut health/microbiome, 330-620mg/day), MaolactinFMR™ (muscle recovery/mobility, 360mg/day), and SuperColoSKN™ (skin health, 2026 launch). All products are developed using the proprietary Maoreka™ AI-driven discovery platform that identifies and extracts functional proteins from bovine colostrum with high biosimilarity to human breast milk proteins. The company positions these as precision nutrition ingredients suitable for dietary supplements, functional foods, beverages, and medical nutrition applications.

Differentiator

Problem solved

Functional benefit

Brands

  • SuperColostrum™: The first colostrum optimized for human biology, delivering a wide range of demonstrated health benefits in just 140mg per day.
  • MaolactinGI™
  • MaolactinFMR™
  • SuperColoSKN™
  • IgHM™
  • Maoreka™

Products and services

  • SuperColostrum™ The first colostrum optimized for human biology, delivering demonstrated health benefits in gut health, vitality, fitness, beauty, and digestion at just 140mg per day. Features over 20% IgHM™ bioactive content, 7x more effective than standard bovine colostrum, and contains no residual veterinary drugs, hormones, or antibiotics. For B2B ingredient customers developing dietary supplement and functional nutrition products.
  • MaolactinGI™ A clinically proven colostrum-based bioactive protein ingredient that supports gut health, promotes balanced microbiome, and helps reduce bloating, constipation, and abdominal discomfort. Works at the biological root to support healthier gut environment with proven symptom alleviation at 330-620 mg/day. The first bio-biotic protein system that goes beyond prebiotics, probiotics, and postbiotics. For B2B supplement and functional food brand customers.
  • MaolactinFMR™ A clinically validated colostrum-based ingredient for recovery, mobility, and healthy aging. Targets muscle damage and chronic low-grade inflammation (inflammaging) to support faster recovery, reduced soreness, and long-term mobility at just 360 mg/day. Backed by randomized double-blind, placebo-controlled clinical trial with 33 healthy active adults. For B2B sports nutrition, active nutrition, and healthy aging brand customers.
  • SuperColoSKN™ Advanced colostrum designed specifically for human skin, delivering biofunctional proteins that support microbiome balance, inflammation control, and barrier function. Features 95%+ structural and functional similarity to human breast milk, 7x greater efficacy than generic colostrum, and 75%+ protein content. Targets anti-inflammatory action and skin resilience. For B2B skincare, beauty-from-within, and nutricosmetics brand customers.
  • COLOSTRUM 2.0 AI-driven bovine colostrum ingredient that uses a proprietary 3D discovery platform to concentrate approximately 400 bioactive proteins with about 95% similarity to human biology. Designed for predictable microbiome modulation and clinically demonstrated digestive benefits at low daily doses. Targets clinical, practitioner, and premium formulation markets positioning for pharmaceutical-grade credibility.

Quantifiable outcome

  • 35% reduction in overall gastrointestinal symptom severity (GSRS) in double-blind clinical trial (n=90)
  • +11 more outcomes

Companies that use MAOLAC

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

MAOLAC technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

MAOLAC partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and flagship.

  • CaldiccoreChannel Partner/ Reseller/ Distributor · 19 February 2026Caldic, a global solutions provider for food and nutrition markets, partnered with Maolac to market and distribute Maolac's portfolio of colostrum-based ingredients across the North American nutrition sector. Products covered include Maolactin-GI, Maolactin-FMR, and Super Colostrum. Commercial rollout is planned for 2026. This is a key distribution partnership enabling Maolac to scale in the North American market.
  • LemmeflagshipOEM/ Whitelabel/ Licensing Partner · 4 November 2025Lemme, a vitamin and supplement brand founded by Kourtney Kardashian Barker, launched new gut health products (Lemme Colostrum Gummies and Lemme Colostrum Liposomal Liquid) formulated with Maolac's scientifically-supported colostrum ingredient. The product launch received strong consumer response and was featured in leading business publications.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

MAOLAC competitors and assessment

Company assessment

Broad incumbents

  • Glanbia Nutritionals: Glanbia Nutritionals supplies whey proteins, milk proteins, and functional ingredient blends to supplement, performance, and food brands globally. It is a broad incumbent competing with Maolac in the dairy/functional-protein ingredient space with significantly greater scale and a wider customer base.
  • Arla Foods Ingredients: Arla Foods Ingredients is a global dairy ingredient supplier (whey proteins, milk fractions, lactose) serving nutrition, health, and performance-food customers worldwide. It is a broad incumbent that competes with Maolac on the dairy-protein ingredients shelf and benefits from much deeper distribution and customer penetration.
  • Kerry Group: Kerry Group is a global taste and nutrition ingredients platform serving food, beverage, and supplement customers. It competes with Maolac in bioactive and functional ingredient categories through its nutrition portfolio and has the scale and customer breadth to bundle Maolac-style innovations into larger accounts.
  • ADM Nutrition: ADM's Nutrition segment is a global supplier of plant- and animal-protein ingredients, flavors, and health-and-wellness solutions for CPG and supplement brands. It is a broad incumbent that addresses the same brand customers as Maolac through protein-ingredient offerings.
  • Hilmar Ingredients: Hilmar Ingredients is a US-based manufacturer of whey protein and dairy ingredient solutions for nutrition and food brands. As an established dairy-protein ingredient incumbent with strong US manufacturing capacity, it overlaps with Maolac's positioning on functional protein ingredients for nutrition customers.
  • Cargill Health & Nutrition: Cargill supplies a broad portfolio of food and nutrition ingredients, including proteins and bioactives, to CPG and supplement manufacturers globally. It competes with Maolac in the functional-ingredient shelf and has the distribution network to reach every customer Maolac targets through Caldic and direct sales.
  • International Flavors & Fragrances (IFF) Health & Biosciences: IFF's Health & Biosciences division produces probiotics, enzymes, and bioactive ingredients for nutrition and dietary-supplement brands. It is a broad incumbent with a microbial-protein discovery infrastructure that is adjacent and partially competitive with Maolac's AI-driven bioactive ingredient work.

Direct peers

  • PanTheryx: PanTheryx is a US-based bovine colostrum ingredient supplier offering branded colostrum powders and formulations for immune and GI health to dietary-supplement and nutrition-brand customers. It is the closest direct competitor to Maolac in colostrum-based B2B ingredients targeting the same supplement and functional-food brand channels.
  • APS Biogroup: APS Biogroup is a Switzerland-based manufacturer of hyperimmune bovine colostrum ingredients (including travelan/Colact/IMMUSE) for gut and immune health, sold primarily to dietary-supplement and functional-food brands. It directly competes with Maolac on colostrum-derived bioactive ingredients and pursues a similar B2B ingredient model.

Emerging players

  • SternVitamin: SternVitamin is a premix and functional-ingredient supplier serving the European dietary-supplement and fortified-food industries. It is a smaller, ingredient-blending specialist whose customer base (vitamin and supplement brands) overlaps with Maolac's targeted B2B segments in functional nutrition formulations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

MAOLAC social profiles

Digital presence

MAOLAC compliance and trust

Trust signal

Compliance3 records

MAOLAC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MAOLAC leadership team

Management profile

Number of profiles

Profiles9 records

MAOLAC funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MAOLAC M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MAOLAC

What does MAOLAC do?

MAOLAC develops and sells colostrum-based bioactive protein ingredients (SuperColostrum™, MaolactinGI™, MaolactinFMR™, SuperColoSKN™) to supplement brands, functional food formulators, and medical nutrition companies. The company uses its proprietary Maoreka™ AI-driven proteomics platform to identify and extract proteins from bovine colostrum with high biosimilarity to human breast milk proteins, delivering clinically validated ingredients effective at 140-620 mg/day.

Is MAOLAC a public or private company?

MAOLAC is a private company. It is classified as venture growth investor backed and is currently operating.

When was MAOLAC founded?

MAOLAC was founded in 2021. It employs 11 to 50 people.

Where is MAOLAC based?

MAOLAC is headquartered in Tirat Hakarmel, Israel, in the Middle East region.

How does MAOLAC make money?

One revenue line is on record: B2B Ingredient Sales.

Who are MAOLAC's main competitors?

Broad incumbents on record are Glanbia Nutritionals, Arla Foods Ingredients, Kerry Group, ADM Nutrition, Hilmar Ingredients, Cargill Health & Nutrition and International Flavors & Fragrances (IFF) Health & Biosciences. Direct peers are PanTheryx and APS Biogroup. SternVitamin is listed as an emerging player.

Does MAOLAC have an API?

No public API is recorded for MAOLAC.

What industry is MAOLAC in?

MAOLAC's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is CRADAOAJ, Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids), with a secondary code of AFAJAHAB, Animal-Derived Protein Ingredients (Egg, Collagen/Gelatin, Blood/Plasma Proteins). Its NAICS code is 3115 and its SIC code is 2020.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CTechMaolac turns cow colostrum into patented health ingredientsMaolac, a biofunctional ingredient company, was selected for ScaleUp House's inaugural cohort. It develops patented proteins and peptides from bovine colostrum for supplements and functional foods. The company is expanding manufacturing capacity and global market access.EIN PresswireMore Startups are Arriving with Working Products, but Fewer are Managing to Raise CapitalIsraeli tech companies raised $7.6 billion in the first half of 2026, a 52% increase, but early-stage funding fell about 50%. MerageNext registration opened, offering $10,000 grants and a $30,000 California program, with top three ventures receiving up to $150,000 in cloud credits.SupplysidesjMaolac debuts AI-driven colostrum ingredientMaolac has launched COLOSTRUM 2.0, an AI-driven bovine colostrum ingredient that uses a proprietary 3D discovery platform to concentrate approximately 400 bioactive proteins with about 95 percent similarity to human biology. The product is designed to provide predictable microbiome modulation and clinically demonstrated digestive benefits at low daily doses, targeting clinical, practitioner, and premium formulation markets. The technology addresses limitations of traditional bovine colostrum including variable bioactive composition and inconsistent dosing, positioning the ingredient for pharmaceutical-grade credibility.PrwebCaldic and Maolac Partner to Bring Clinically Backed Colostrum Based Innovative Ingredients to the North American Nutrition MarketCaldic, a global solutions provider for food and nutrition markets, has partnered with Maolac, a deep tech biotechnology company, to market and distribute Maolac's portfolio of colostrum-based ingredients across the North American nutrition sector, with commercial rollout planned for 2026. Maolac's technology uses AI-driven proteomics to identify and extract functional proteins from bovine colostrum that are structurally similar to those in human breast milk, producing ingredients for gut health, muscle recovery, joint support, and immune balance. The partnership gives Caldic access to Maolac's differentiated product line including Maolactin-GI, Maolactin-FMR, and Super Colostrum for the North American market.PlanetfoodVCs Love Future FoodTech But Just Not When Women Are Behind ItWomen lead nearly one-third of Israeli FoodTech startups but attract only 4% of total sector investment, dropping to 2.1% globally, despite running innovative companies in lab-grown foods and AI-designed proteins. The Modern Agriculture Foundation is calling for nominations for its Leading Women in Israeli FoodTech award to address this funding disparity. Examples include Racheli Vizman's SavorEat, which produces 3D-printed plant-based meals, and Maya Ashkenazi Otmazgin's MAOLAC, developing bioactive proteins inspired by breast milk.WebcapitalriesgoPascual Innoventures invierte 1,5M en las startups Novo Dairy, Zero Cow Factory, Ergo BioScience y MaolacPascual Innoventures, the corporate venturing arm of Pascual, has invested 1.5 million euros in four international startups: Novo Dairy, Zero Cow Factory, Ergo BioScience, and Maolac. These companies were selected from the first two editions of Mylkcubator, an incubation program co-founded by Pascual and Eatable Adventures, to develop alternative dairy proteins and ingredients. The investment supports the launch of the third edition of Mylkcubator, which expands its scope to include other food categories such as eggs, coffee, and cocoa.FinSMEsMaolac Raises USD3.2M in Seed FundingIsrael-based foodtech startup Maolac raised USD3.2 million in a seed funding round led by OurCrowd with participation from several other investors. The company plans to utilize the capital to construct a facility for small-scale production, analytics, and clinical trials. This infrastructure will support the development of its bio-convergence platform aimed at creating anti-inflammatory products derived from bovine colostrum.IFTTTBovine colostrum food co Maolac raises $3.2mIsraeli foodtech startup Maolac raised $3.2 million in seed funding led by OurCrowd. The company extracts functional proteins from bovine colostrum, which is 95% equivalent to human breast milk, and will use the funds to build a production facility. It is in talks with dairy producers and food companies for joint development.TechCrunchMaolac creating protein with breast milk-like benefitsMaolac, an Israeli food tech startup, extracts proteins from bovine colostrum to create a breast-milk-like supplement. The company raised $3.2 million in seed funding and plans to launch anti-inflammatory products in 2023. It targets a $22 billion annual market for functional ingredients.DairyprocessingBreast milk-inspired startup Maolac closes $3.2 million seed roundIsraeli foodtech startup Maolac has closed a $3.2 million seed funding round led by OurCrowd to build a production facility for functional proteins extracted from bovine colostrum. The company plans to use these breast milk-equivalent ingredients to develop anti-inflammatory products targeting athletes and older adults, aiming to disrupt the global immune-boosting market.